← Eichor
Study identifier: NCT04533217 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Condition: Vertebral Fracture · Multiple Myeloma  ·  Sponsor: Spine Centre of Southern Denmark

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).

This description comes directly from the study's public registry record.

Talk to the study team

Line Wickstroem, MD  ·  +4524411994  ·  line.adsboll.wickstrom@rsyd.dk

Mikkel Andersen, Professor  ·  +4540344069  ·  mikkel.andersen2@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Center for Spine Surgery and ResearchMiddelfart, Region Syddanmark, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04533217